Bone Marrow Changes in Acute Leukemia Patients
Author Information
Author(s): Sadovskaya Aleksandra, Petinati Nataliya, Shipounova Irina, Drize Nina, Smirnov Igor, Pobeguts Olga, Arapidi Georgiy, Lagarkova Maria, Karaseva Luiza, Pokrovskaya Olga, Kuzmina Larisa, Vasilieva Anastasia, Aleshina Olga, Parovichnikova Elena
Primary Institution: National Medical Research Center for Hematology, Moscow
Hypothesis
The study aims to elucidate the alterations in multipotent mesenchymal stromal cells (MSCs) at the onset and after therapy in patients with acute leukemia.
Conclusion
Acute leukemia causes significant and largely irreversible changes in bone marrow MSCs, affecting their ability to maintain normal blood cell production.
Supporting Evidence
- MSCs from acute leukemia patients showed altered growth characteristics compared to healthy donors.
- Gene expression analysis revealed significant changes in factors important for hematopoiesis.
- Proteomic and secretomic analyses indicated a decrease in the secretion of growth factors in AL-MSCs.
Takeaway
This study found that patients with acute leukemia have damaged bone marrow cells that help make blood, and this damage doesn't fully heal even after treatment.
Methodology
The study analyzed MSCs from the bone marrow of 78 acute leukemia patients and healthy donors, examining their growth characteristics, gene expression, proteome, and secretome.
Potential Biases
Potential bias due to the variability in patient demographics and treatment regimens.
Limitations
Not all patients had MSC samples available in remission, leading to differences in sample sizes for comparisons.
Participant Demographics
42 patients with acute myeloid leukemia (AML) and 36 with acute lymphoblastic leukemia (ALL).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website